Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide patients had: 7.7 lbs (3.5 kg) more weight loss than placebo (with a 1 mg injection dose) 5.7 lbs (2.6 kg) more weight loss than placebo (with a 0.5 mg injection dose) Ozempic injection helped with weight loss and weight loss maintenance when used with diet and exercise in clinical trials, however, it is not FDA-approved for weight loss
This allows for a safer and more effective procedure with minimised risks of adverse effects
Implications for employers Each year for the past three years, Mercers National Survey of Employer-Sponsored Health Plans has found more large employers (500 or more employees) offering coverage for weight-loss medications, highlighting the importance they place on facilitating access to affordable medication to manage chronic conditions, including obesity
FEBS J 277(20):41124125 Akerfelt M, Vihervaara A, Laiho A, Conter A, Christians ES, Sistonen L, Henriksson E (2010) Heat shock transcription factor 1 localizes to sex chromatin during meiotic repression
